PD-2024

N/A

Report date: 2022/12/12 15:40:45

Base Information

Drug NamePD-2024
Drug Alias NameIDTIDT, P2D Biosciencesisoindolin-1,3 dithionePD-2024
ClassificationBiologics
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsFrontotemporal DementiaAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesP2d, Inc
China Registration ClassN/A

Develop Information

Active CompaniesP2d, Inc
Inactive CompaniesN/A
Active IndicationsFrontotemporal DementiaAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A